Search Within

Shanu Modi

  1. "Devika Gajria"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
Groups
  1. Breast Medicine Service (15)
  2. Department of Medicine (15)
  3. Solid Tumor Oncology Division (15)
  4. Epidemiology and Biostatistics (13)
  5. Survivorship Research (13)
  6. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (11)

More Groups

People
  1. Devika Gajria (15)
  2. Shari Goldfarb (10)
  3. Clifford Hudis (9)
  4. Sujata Patil (9)
  5. Chau Dang (8)
  6. Diana Lake (8)

More People

Years
  1. 2023 (1)
  2. 2019 (2)
  3. 2018 (1)
  4. 2016 (1)
  5. 2015 (2)
  6. 2014 (1)

More Years

Publications
  1. Journal of Clinical Oncology (6)
  2. Cancer Research (5)
  3. JAMA Dermatology (2)
  4. Clinical Breast Cancer (1)
  5. European Heart Journal (1)
Publishers
  1. American Society of Clinical Oncology (6)
  2. American Association for Cancer Research (5)
  3. American Medical Association (2)
  4. Elsevier Inc. (1)
  5. Oxford University Press (1)

Results (15)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Timing of exercise therapy when initiating adjuvant chemotherapy for breast cancer: A randomized trial
    Journal Article

    Scott, J. M.; Lee, J.; Herndon, J. E.; Michalski, M. G.; Lee, C. P.; O'Brien, K. A.; Sasso, J. P.; Yu, A. F.; Rowed, K. A.; Bromberg, J. F.; more...
    European Heart Journal (2023)

    Fulltext@MSK | Save
  • CDK4/6 plus aromatase inhibitor-induced alopecia in breast cancer patients
    Meeting Abstract

    Chan, D.; Freites Martinez, A. D.; Goldfarb, S. B.; Modi, S.; Gajria, D.; Lacouture, M. E.
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Assessment of quality of life and treatment outcomes of patients with persistent postchemotherapy alopecia
    Journal Article

    Freites-Martinez, A.; Chan, D.; Sibaud, V.; Shapiro, J.; Fabbrocini, G.; Tosti, A.; Cho, J.; Goldfarb, S.; Modi, S.; Gajria, D.; more...
    JAMA Dermatology (2019)

    Fulltext@MSK | Save
  • Endocrine therapy-induced alopecia in patients with breast cancer
    Journal Article

    Freites-Martinez, A.; Shapiro, J.; Chan, D.; Fornier, M.; Modi, S.; Gajria, D.; Dusza, S.; Goldfarb, S.; Lacouture, M. E.
    JAMA Dermatology (2018)

    Fulltext@MSK | Save
  • A pilot study of dose-dense paclitaxel with trastuzumab and lapatinib for node-negative HER2-overexpressed breast cancer
    Journal Article

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S. M.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G. M.; Drullinsky, P. R.; Gajria, D.; Goldfarb, S. B.; Comen, E. A.; more...
    Clinical Breast Cancer (2016)

    Fulltext@MSK | Save
  • A phase I/II study of neratinib plus temsirolimus in HER2+ metastatic breast cancer reveals ongoing HER2 pathway dependence in many patients despite several lines of HER2 targeted therapy
    Meeting Abstract

    Gajria, D.; Modi, S.; Saura, C.; Sakr, R.; Solano, K.; Won, H.; Pannu, H.; Patil, S.; Lake, D.; Traina, T.; more...
    Cancer Research (2015)

    Fulltext@MSK | Save
  • Phase II study of paclitaxel given once per week along with trastuzumab and pertuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer
    Journal Article

    Dang, C.; Iyengar, N.; Datko, F.; D'Andrea, G.; Theodoulou, M.; Dickler, M.; Goldfarb, S.; Lake, D.; Fasano, J.; Fornier, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II feasibility study of paclitaxel (T) with trastuzumab (H) and lapatinib (L) for node-negative, HER2-positive breast cancer (BC)
    Meeting Abstract

    Iyengar, N. M.; Fornier, M. N.; Sugarman, S.; Theodoulou, M.; Troso-Sandoval, T. A.; D'Andrea, G.; Drullinsky, P.; Fasano, J.; Gajria, D.; Goldfarb, S. B.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Using (124)I-PU-H71 PET imaging to predict intratumoral concentration in patients on a phase I trial of PU-H71
    Meeting Abstract

    Gerecitano, J. F.; Modi, S.; Gajria, D.; Taldone, T.; Alpaugh, M.; DaGama, E. G.; Uddin, M.; Chiosis, G.; Lewis, J. S.; Larson, S. M.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Phase II study of pertuzumab, trastuzumab, and weekly paclitaxel in patients with HER2-overexpressing metastatic breast cancer (MBC)
    Meeting Abstract

    Datko, F. M.; D'Andrea, G.; Dickler, M. N.; Goldfarb, S. B.; Theodoulou, M.; Lake, D.; Fornier, M. N.; Modi, S.; Fasano, J.; Comen, E. A.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save